527 related articles for article (PubMed ID: 31009834)
1. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes?
Jeffirs SM; Jarnecke AM; Flanagan JC; Killeen TK; Laffey TF; Back SE
Drug Alcohol Depend; 2019 Jun; 199():70-75. PubMed ID: 31009834
[TBL] [Abstract][Full Text] [Related]
2. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.
Brown DG; Flanagan JC; Jarnecke A; Killeen TK; Back SE
J Ethn Subst Abuse; 2022; 21(3):1141-1164. PubMed ID: 33111647
[TBL] [Abstract][Full Text] [Related]
3. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
[TBL] [Abstract][Full Text] [Related]
4. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
[TBL] [Abstract][Full Text] [Related]
5. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.
Gros DF; Lancaster CL; Horner MD; Szafranski DD; Back SE
Compr Psychiatry; 2017 Oct; 78():48-53. PubMed ID: 28803041
[TBL] [Abstract][Full Text] [Related]
6. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
[TBL] [Abstract][Full Text] [Related]
7. To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD.
Lozano BE; Gros DF; Killeen T; Jaconis M; Beylotte FM; Boyd S; Back SE
Am J Addict; 2015 Oct; 24(7):578-81. PubMed ID: 26300219
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders.
Kehle-Forbes SM; Chen S; Polusny MA; Lynch KG; Koffel E; Ingram E; Foa EB; Van Horn DHA; Drapkin ML; Yusko DA; Oslin DW
Drug Alcohol Depend; 2019 Dec; 205():107647. PubMed ID: 31675546
[TBL] [Abstract][Full Text] [Related]
9. Study design, interventions, and baseline characteristics for the Substance use and TRauma Intervention for VEterans (STRIVE) trial.
Kehle-Forbes SM; Drapkin ML; Foa EB; Koffel E; Lynch KG; Polusny MA; Van Horn DH; Yusko DA; Charlesworth M; Blasco M; Oslin DW
Contemp Clin Trials; 2016 Sep; 50():45-53. PubMed ID: 27444425
[TBL] [Abstract][Full Text] [Related]
10. Examining Insomnia and PTSD Over Time in Veterans in Residential Treatment for Substance Use Disorders and PTSD.
Colvonen PJ; Ellison J; Haller M; Norman SB
Behav Sleep Med; 2019; 17(4):524-535. PubMed ID: 29364693
[No Abstract] [Full Text] [Related]
11. Increased Resilience is Associated with Positive Treatment Outcomes for Veterans with Comorbid PTSD and Substance Use Disorders.
McGuire AP; Mota NP; Sippel LM; Connolly KM; Lyons JA
J Dual Diagn; 2018; 14(3):181-186. PubMed ID: 29668364
[TBL] [Abstract][Full Text] [Related]
12. Examining changes in negative mood regulation expectancies, posttraumatic stress disorder, depression, and substance use following integrated cognitive-behavioral therapy.
Siegel EY; Haller M; Cui R; Trim RS; Tate SR; Norman SB
Subst Abus; 2017; 38(4):468-472. PubMed ID: 28632462
[TBL] [Abstract][Full Text] [Related]
13. A cognitive processing therapy-based treatment program for veterans diagnosed with co-occurring posttraumatic stress disorder and substance use disorder: The relationship between trauma-related cognitions and outcomes of a 6-week treatment program.
Peck KR; Coffey SF; McGuire AP; Voluse AC; Connolly KM
J Anxiety Disord; 2018 Oct; 59():34-41. PubMed ID: 30248534
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial.
Kehle-Forbes SM; Nelson D; Norman SB; Schnurr PP; Shea MT; Ackland PE; Meis L; Possemato K; Polusny MA; Oslin D; Hamblen JL; Galovski T; Kenny M; Babajide N; Hagedorn H
Contemp Clin Trials; 2022 Sep; 120():106876. PubMed ID: 35987487
[TBL] [Abstract][Full Text] [Related]
15. The role of posttraumatic guilt and anger in integrated treatment for PTSD and co-occurring substance use disorders among primarily male veterans.
Saraiya TC; Badour CL; Jones AC; Jarnecke AM; Brown DG; Flanagan JC; Killeen TK; Back SE
Psychol Trauma; 2023 Nov; 15(8):1293-1298. PubMed ID: 35025558
[TBL] [Abstract][Full Text] [Related]
16. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial for Veterans with PTSD and Substance Use Disorder: Creating Change versus Seeking Safety.
Najavits LM; Krinsley K; Waring ME; Gallagher MW; Skidmore C
Subst Use Misuse; 2018 Sep; 53(11):1788-1800. PubMed ID: 29461920
[TBL] [Abstract][Full Text] [Related]
18. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders.
Scott JC; Lynch KG; Cenkner DP; Kehle-Forbes SM; Polusny MA; Gur RC; Chen S; Foa EB; Oslin DW
J Consult Clin Psychol; 2021 Nov; 89(11):937-946. PubMed ID: 34881912
[TBL] [Abstract][Full Text] [Related]
20. Comparison of treatment outcomes for veterans with posttraumatic stress disorder with and without comorbid substance use/dependence.
Fontana A; Rosenheck R; Desai R
J Psychiatr Res; 2012 Aug; 46(8):1008-14. PubMed ID: 22743092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
